DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Schühlen H, Hadamitzky M, Walter H, Ulm K, Schömig A.
Major benefit from antiplatelet therapy for patients at high
risk for adverse cardiac events after coronary Palmaz-Schatz stent
placement: analysis of a prospective risk stratification protocol
in the Intracoronary Stenting and Antithrombotic Regimen (ISAR)
trial.
Circulation 1997; 95: 2015-2021
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.